A Quantitative Optical Sensor to Monitor Vascular Physiology; A Healthy Volunteer Study
1 other identifier
observational
10
1 country
1
Brief Summary
This study aims to evaluate the Zenalux IM1, an optical spectroscopy device with a pressure sensor. The pressure sensor is intended to overcome the inconsistencies attributable to variations in use of the device. This study will involve using the device on healthy volunteers. Three tissue parameters will be used to analyze the pressure effects in two ways: within- and across-subject variability. Measurements will be taken under the tongue and on the inside of the cheek. The device is noninvasive and is approved for preclinical use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jun 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2014
CompletedFirst Posted
Study publicly available on registry
December 22, 2014
CompletedStudy Start
First participant enrolled
June 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedJuly 2, 2017
June 1, 2017
4 months
December 17, 2014
June 28, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
minimum contact pressure required for spectroscopic measurements
at the time the optical measurements are collected
Eligibility Criteria
Healthy Volunteers
You may qualify if:
- Healthy volunteer with no presentation of disease (such as no complaints or self-reported oral symptoms or lesions; no cold or flu like symptoms) that would affect the reflective measurements in the oral cavity
- Age 18 or older
- Subjects of all ethnic and gender groups will be included
- Ability to understand and the willingness to sign a written informed consent document
You may not qualify if:
- Subjects considered in "vulnerable" populations such as children under the age of 18
- Complaint of oral symptoms or lesions
- Current cold or flu like symptoms (self-reported)
- Pregnancy (self-reported by menstrual history)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Duke University Medical Center
Durham, North Carolina, 27705, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Mark Dewhirst, DVM, PhD
Duke University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 17, 2014
First Posted
December 22, 2014
Study Start
June 1, 2016
Primary Completion
October 1, 2016
Study Completion
October 1, 2016
Last Updated
July 2, 2017
Record last verified: 2017-06